These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3829978)

  • 21. Alterations in DNA, RNA and protein contents in liver and kidney of mice treated with ochratoxin and their amelioration by Emblica officinalis aqueous extract.
    Verma R; Chakraborty D
    Acta Pol Pharm; 2008; 65(1):3-9. PubMed ID: 18536167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
    Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
    Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is ochratoxin a nephrotoxic in human beings?
    Godin M; Fillastre JP; Simon P; Francois A; Roy FL; Morin JP
    Adv Nephrol Necker Hosp; 1997; 26():181-206. PubMed ID: 8922134
    [No Abstract]   [Full Text] [Related]  

  • 24. Protective role of melatonin and coenzyme Q10 in ochratoxin A toxicity in rat liver and kidney.
    Sutken E; Aral E; Ozdemir F; Uslu S; Alatas O; Colak O
    Int J Toxicol; 2007; 26(1):81-7. PubMed ID: 17365150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: correlation with DNA-adduct formation.
    Faucet-Marquis V; Pont F; Størmer FC; Rizk T; Castegnaro M; Pfohl-Leszkowicz A
    Mol Nutr Food Res; 2006 May; 50(6):530-42. PubMed ID: 16671059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats.
    Pfohl-Leszkowicz A; Pinelli E; Bartsch H; Mohr U; Castegnaro M
    Mol Carcinog; 1998 Oct; 23(2):76-85. PubMed ID: 9808161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of diisopropyl phosphorofluoridate (DFP) on renal transport.
    Baggett J; Hoskins B; Ho IK; Berndt WO
    Dev Toxicol Environ Sci; 1983; 11():447-50. PubMed ID: 6677484
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.
    Adler M; Müller K; Rached E; Dekant W; Mally A
    Carcinogenesis; 2009 Apr; 30(4):711-9. PubMed ID: 19237604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adaptive changes in succinate dehydrogenase activity in different functional states of rat kidney].
    Natochin IuV; Reznik LV; Shakhmatova EI; Lavrova EA
    Dokl Akad Nauk SSSR; 1977; 237(2):487-9. PubMed ID: 590071
    [No Abstract]   [Full Text] [Related]  

  • 30. Minimum tolerable exposure period and maximum threshold dietary intake of ochratoxin A for causing renal cancer in male Dark Agouti rats.
    Mantle PG
    Food Chem Toxicol; 2009 Oct; 47(10):2419-24. PubMed ID: 19577606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig.
    Faucet V; Pfohl-Leszkowicz A; Dai J; Castegnaro M; Manderville RA
    Chem Res Toxicol; 2004 Sep; 17(9):1289-96. PubMed ID: 15377164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotransformation and nephrotoxicity of ochratoxin B in rats.
    Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
    Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of renal mRNA species abundance by ochratoxin A.
    Meisner H; Polsinelli L
    Biochem Pharmacol; 1986 Feb; 35(4):661-5. PubMed ID: 3753873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma.
    Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Delatour T; Mantle P; Cavin C; Schilter B
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):174-81. PubMed ID: 17651772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Calcium concentration in the skin of male rats exposed to high doses of ochratoxin A (OTA)].
    Bulikowski W; Borzecki A; Skorupski R; Trocka K; Lingas W
    Med Pr; 2005; 56(5):363-6. PubMed ID: 16483006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylsalicylic acid and the kidneys.
    Raab WP
    Helv Med Acta; 1969 Mar; 34(6):498-502. PubMed ID: 5779215
    [No Abstract]   [Full Text] [Related]  

  • 38. Ochratoxin A-induced teratogenesis in rats: partial protection by phenylalanine.
    Mayura K; Parker R; Berndt WO; Phillips TD
    Appl Environ Microbiol; 1984 Dec; 48(6):1186-8. PubMed ID: 6517585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicologic changes in rats fed graded dietary levels of ochratoxin A.
    Munro IC; Moodie CA; Kuiper-Goodman T; Scott PM; Grice HC
    Toxicol Appl Pharmacol; 1974 May; 28(2):180-8. PubMed ID: 4137328
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine.
    Creppy EE; Röschenthaler R; Dirheimer G
    Food Chem Toxicol; 1984 Nov; 22(11):883-6. PubMed ID: 6542055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.